1 / 7

Sofosbuvir, Ribavirin, GS - 0938 QUANTUM

Phase 2b. Treatment Naïve . Sofosbuvir, Ribavirin, GS - 0938 QUANTUM. Lalezari JP, et al. EASL. 2013; Abstract 845. . Sofosbuvir, Ribavirin, & GS-0938 in Treatment Naïve QUANTUM Trial: Features. Source: Lalezari JP, et al. EASL. 2013; Abstract 845. .

kylee
Télécharger la présentation

Sofosbuvir, Ribavirin, GS - 0938 QUANTUM

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Phase 2b TreatmentNaïve Sofosbuvir, Ribavirin, GS-0938QUANTUM Lalezari JP, et al. EASL. 2013; Abstract 845.

  2. Sofosbuvir, Ribavirin, & GS-0938 in Treatment NaïveQUANTUM Trial: Features Source: Lalezari JP, et al. EASL. 2013; Abstract 845.

  3. Sofosbuvir, Ribavirin, & GS-0938 in Treatment NaïveQUANTUM Trial: Design 0 12 24 36 Week SVR12 n =28 GS-0938* SVR12 n = 25 SOF + GS-0938* SVR12 n = 25 SOF + RBV SVR12 n = 25 SOF + RBV + GS-0938* SVR12 n =27 GS-0938* SVR12 n = 25 SOF + GS-0938* SVR12 n = 25 SOF + RBV SVR12 n = 29 SOF + RBV + GS-0938* Randomized to available arm n = 26 Placebo Study Modification: all GS-0938 arms stopped; patients without SVR12 retreated with SOF + RBV x 24 weeks N =14 Drug DosingSofosbuvir (SOF): 400 mg once dailyRibavirin (RBV) weight-based and divided bid: 1000 mg/day if < 75 kg or 1200 mg/day if ≥ 75 kgGS-0938: 300 mg once daily Source: Lalezari JP, et al. EASL. 2013; Abstract 845.

  4. Sofosbuvir, Ribavirin, & GS-0938 in Treatment NaïveQUANTUM Trial: Results QUANTUM: SVR12 Results for Completed Arms (all genotypes) 14/25 13/25 92/132 SOF = sofosbuvir; RBV = ribavirin Source: Lalezari JP, et al. EASL. 2013; Abstract 845.

  5. Sofosbuvir, Ribavirin, & GS-0938 in Treatment NaïveQUANTUM Trial: Results QUANTUM: SVR12 Results for Patients with Genotype 1 10/19 9/19 69/105 SOF = sofosbuvir; RBV = ribavirin Source: Lalezari JP, et al. EASL. 2013; Abstract 845.

  6. Sofosbuvir, Ribavirin, & GS-0938 in Treatment NaïveQUANTUM Trial: Results QUANTUM: SVR12 Results for Patients with Genotype 1 8/15 2/4 7/15 2/4 57/80 12/25 SOF = sofosbuvir; RBV = ribavirin Source: Lalezari JP, et al. EASL. 2013; Abstract 845.

  7. This slide deck is from the University of Washington’s Hepatitis C Online and Hepatitis Web Study projects. Hepatitis C Onlinewww.hepatitisc.uw.edu Hepatitis Web Studyhttp://depts.washington.edu/hepstudy/ Funded by a grant from the Centers for Disease Control and Prevention.

More Related